Anderson Cynthia Lynn
SEC CIK 1989905 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | CFO | 12.8K | — | — | 3 | 2024-06-28 | 2025-06-30 |
Most active insiders at VTGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Prince Joshua S. | COO | — | — |
| 2 | Adler Reid G. | CLO | — | — |
| 3 | Tressler Nick B. | CFO | — | — |
| 4 | Singh Shawn | Pres, CEO, Dir | — | — |
Anderson Cynthia Lynn made no open-market trades at VTGN in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-01 | 2025-06-30 | VTGN | Vistagen Therapeutics, Inc. | Anderson Cynthia Lynn | CFO | A - Grant | $1.70 | +6,617 | 12.8K | +107% | +$11.2K | |
| 2025-01-13 | 2024-12-31 | VTGN | Vistagen Therapeutics, Inc. | Anderson Cynthia Lynn | CFO | A - Grant | $2.51 | +2,592 | 6,184 | +72% | +$6,506 | |
| 2024-07-02 | 2024-06-28 | VTGN | Vistagen Therapeutics, Inc. | Anderson Cynthia Lynn | CFO | A - Grant | $2.96 | +3,592 | 3,592 | New | +$10.6K |
Purchase Sale Sale after option exercise All abbreviations